[Form 4] PRECIGEN, INC. Insider Trading Activity

Rhea-AI Filing Summary

Helen Sabzevari, President and CEO and a director of Precigen, Inc. (PGEN), reported the vesting of performance stock units. On 09/12/2025, the second installment of PSUs granted August 28, 2024 vested, resulting in 825,000 shares of common stock being issued or payable in cash equivalent value. The filing lists the shares as directly owned following the transaction. The Form 4 was signed on behalf of Ms. Sabzevari by an attorney-in-fact and filed on 09/16/2025. The document states each PSU converts to one share or an equivalent cash amount.

Positive

• Performance condition achieved: The filing explicitly states the PSUs vested based on meeting the applicable performance condition.
• Substantial equity alignment: The reporting person received 825,000 shares (or cash equivalent), aligning executive compensation with company performance.

Negative

• None.

Insights

Executive Compensation Analyst

TL;DR: A significant PSU installment vested, delivering 825,000 shares to the CEO following achieved performance conditions.

The filing documents the vesting of the second installment of PSUs originally granted 08/28/2024, which converted into 825,000 shares (or cash equivalent) on 09/12/2025 and are held directly by the reporting person. This is a compensation realization tied explicitly to performance metrics rather than an open-market purchase or sale. For stakeholders, vesting confirms that the specific performance condition for that tranche was met; the filing does not disclose the performance metric thresholds, dilution impact, or post-vesting disposition plans.

Corporate Governance Specialist

TL;DR: The director/CEO received a material equity payout via PSUs, confirming plan mechanics executed as granted.

The Form 4 shows a routine, compensation-driven change in beneficial ownership: 825,000 PSUs vested and converted to common stock or cash equivalent. The reporting person is both an officer and director, and the transaction is recorded as direct ownership following vesting. The filing is procedural and informative for governance records; it does not indicate any trading intent or change in control, nor does it provide details on further transfers or whether shares will be held or sold.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

Sabzevari Helen

(Last) (First) (Middle)

20374 SENECA MEADOWS PARKWAY

(Street)

GERMANTOWN MD 20876

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
PRECIGEN, INC. [ PGEN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	President and CEO

3. Date of Earliest Transaction (Month/Day/Year)
09/12/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Performance Stock Units	(1)(2)	09/12/2025		A		825,000		(1)(2)	(1)(2)	Common Stock	825,000	$0	825,000	D

Explanation of Responses:

1. Represents the vesting of the second installment of performance stock units ("PSUs") originally granted on August 28, 2024 based on the achievement of the applicable performance condition for such installment.

2. Each PSU is payable in a share of the Issuer's common stock or in a cash amount having an equivalent value.

	/s/ Helen Sabzevari, by Donald P. Lehr, as attorney-in-fact	09/16/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Helen Sabzevari report on Form 4 for PGEN?

She reported the vesting of 825,000 performance stock units on 09/12/2025, resulting in 825,000 shares of common stock (or cash equivalent) held directly.

When did the PSUs vest and when was the Form 4 filed for PGEN?

The PSUs vested on 09/12/2025 and the Form 4 was signed and filed on 09/16/2025.

Were the vested PSUs convertible to cash for PGEN?

Yes. The filing states each PSU is payable in one share of common stock or a cash amount having equivalent value.

What roles does the reporting person hold at Precigen (PGEN)?

Helen Sabzevari is reported as both President and CEO and a director of Precigen.

How many shares does the reporting person beneficially own after the transaction?

The filing reports 825,000 shares beneficially owned following the reported transaction.